Please assess the completion status of the following clinical trial:

Trial Title: Radiation Therapy in Treating Patients With Prostate Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed prostate cancer~  * T1b-T3a, N0, M0 (stage II or III)~* Prostate-specific antigen at least 50 ng/mL~PATIENT CHARACTERISTICS:~Age:~* Not specified~Performance status:~* WHO 0-1~Life expectancy:~* Not specified~Hematopoietic:~* WBC greater than 4,000/mm\^3~* Platelet count greater than 100,000/mm\^3~* Hemoglobin greater than 11 g/dL~Hepatic:~* Not specified~Renal:~* Not specified~Other:~* No significant past medical history that would preclude radical radiotherapy~* No condition that would preclude standard radiotherapy~* No hip prosthesis~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* Not specified~Endocrine therapy:~* No prior androgen deprivation therapy~Radiotherapy:~* No prior pelvic radiotherapy~Surgery:~* No prior radical prostatectomy

- Gender: MALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).